Search
for
Sort by
Research 91–120 of 1000+
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Immune therapies for alopecia areata: evidence and new perspectives
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Follicular Cell Implantation: An Emerging Cell Therapy for Hair Loss
- Eavesdropping on the conversation between immune cells and the skin epithelium
- A case report of alopecia totalis associated with permanent hair dye use
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Hair Today
- Hair growth control by innate immunocytes: Perifollicular macrophages revisited
- Hair(y) Matters in Melanoma Biology
- Hair development and Langerhans cell migration during human embryogenesis
- Meeting report: The 15thannual meeting of the European hair research society
- Sequential immunotherapy for alopecia areata: phase-driven immune rebalancing
- 1368 Does mitochondrial dysfunction drive immune privilege collapse in lichen planopilaris pathogenesis?
- Alopecia areata − animal models
- Frontiers in alopecia areata pathobiology research
- An update on alopecia areata
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Oxidative stress and alopecia areata
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- Alopecia Areata
- Understanding Alopecia Areata: An Integrative Review of Causes, Mechanisms, and Management Strategies
- Stem cell-based therapies for alopecia areata: a narrative review
- Human regulatory γδT lymphocytes as novel autoimmunity-protective cells: Lessons from alopecia areata
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- The potential of regulatory T cell-based therapies for alopecia areata
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- ALOPESIA AREATA SEBAGAI SEKUELE POST REINFEKSI COVID-19